Abstract
Cellulite affects more than 80% females and is an aesthetically troublesome issue. The clinical manifestation is nodules and fibrosis in subcutaneous areas of the pelvic region, predominantly on the buttocks and thighs. The etiology is multifactorial consisting of genetic tendency, hormonal disorders, and endothelial disruption. There is no satisfactorily proven theory for the clinical presentation and the treatment modalities of cellulite. There are limited number of peer-reviewed studies outlining the effective cellulite treatment protocols. The chapter summarizes the probable pathophysiology, classification, and various treatment options that are documented in literature. Newer, emerging treatment options for cellulite are also mentioned that can lead to future successful outcomes in cellulite removal.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Cellulite
- Adipocytes
- Pathophysiology
- Endothelial dysfunction
- Hormonal disorders
- Endermologie
- Radiofrequency
- Lasers
- Subcision
- Phosphatidylcholine
- Mesotherapy
- Collagenase clostridium histolyticum
1 Introduction
Cellulite is a common lipodystrophy or skin composition disorder mostly affecting women of different ages from maturation to menopause. Medically named as liposclerosis, edematofibrosclerosis, edematous adiposity, gynoid lipodystrophia, and dermopanniculosis deformans [1,2,3,4], cellulite is often referred to as “cottage cheese” or “orange peel” because of its characteristic appearance. The affected skin displays tuberosity, fissures, and depressions mostly on buttocks, thighs, or hips where fat is under the influence of estrogen [5, 6]. Cellulite can also be found in the breasts, in the lower abdomen, arms, and nape—areas where deposition of the adipose tissue is commonly observed [1, 5].
Even though no accurate epidemiologic data exist on its prevalence, it is thought to affect 80–90% of postpubertal women [7] and is rarely seen in men. The common advent around 20–30 years of age has led to the possibility of hormonal etiology.
Goldman described cellulite as a normal physiologic state in postpubescent females that enhances adipose retention to guarantee sufficient caloric availability for pregnancy and lactation [8].
Cellulite is mostly seen in people who are overweight or obese, but also in people having correct body mass [9,10,11]. However, being overweight exacerbates the presence of cellulite. Some of the contributing factors for cellulite are as follows [12,13,14]:
-
1.
Genetic predisposition
-
2.
Hormonal imbalance
-
3.
High body mass index
-
4.
Sedentary lifestyle
-
5.
Smoking
-
6.
Inadequate diet
-
7.
Metabolic disorders like diabetes
-
8.
Cardiovascular diseases
-
9.
Posture defects
-
10.
Emotional disorders
2 Histopathology
The epidermis is typical. A discreet perivascular lymphocytic infiltrate is seen in papillary and high reticular dermis, as well as in the normal skin. The collagen fibers in the superior layers of the dermis are to some extent edematous. The eosinophilic coloration of the collagen fibers is lighter than in the normal skin. No sign of fibrosis, sclerosis, or hyalinization is found. The elastic fibers are reduced in the subepidermic plexus; the fragments cling together in the deeper layers of the dermis. In the arrectores musculi pilorum region, there are indistinct signs of edema and, occasionally, of vacuolar degeneration. The blood vessels do not display pathological features. The superior dermis lymphatic vessels are visibly expanded. Fat cells in the subcutaneous tissue appear enlarged. The adipose tissue’s septa are normal but may present discreet edema [15].
3 Pathophysiology
Cellulite is a complex result of genetic predisposition, and metabolic and biochemical disturbances. Based on magnetic resonance imaging (MRI) and gross ex vivo and in vivo examination, cellulite is postulated to be the result of the herniation of fat through perpendicularly oriented collagen fibrous septa. The collagenous septa course through the subcutaneous tissue, from the deep fascia and attach just under the skin. These septations have variable thickness and distribution in patients with cellulite [16].
When a patient is standing, the fat that encircles the fibrous bands projects outward, giving the “dimpling” appearance of cellulite [17].
Tissue vascularity and inflammation have also been assumed to play a role in cellulite development. It is hypothesized that adipocytes in cellulite prone areas have unique biochemical properties and are more resistant to lipolysis [18]. De Godoy and colleagues [19] hypothesized that an accumulation of fluids in the interstitial space, of both the lymphatic and venous systems, produces the changes that favor the development of cellulite. The accumulation of certain macromolecules results in local inflammation hindering the exchange of particles between both systems which leads to stasis in the lymphatic system that results in cellulite [19]. As a result of stasis, increased microedema results in further stress on the subcutaneous fat layer and surrounding connective tissue and collagen. In response, the number and thickness of reticular fibers intensifies which leads to accentuation of skin irregularities and ultimately the appearance of cellulite [20].
4 Etiopathogenesis
A variety of reasons contribute to the development of cellulite including structural, circulatory, hormonal, and inflammatory factors [21,22,23].
The three main etiologic theories are based on anatomical and hormonal alterations, microcirculation, and chronic inflammatory processes.
4.1 Anatomical and Hormonal Alterations
Anatomical hypothesis is grounded on the fact that there are differences between men and women regarding the structural characteristics of subcutaneous fat lobules and of the conjunctive tissue septa that separate them. According to this philosophy, originally detailed by Nurnberger and Muller [15], the appearance of cellulite is caused by the protrusion of fat in the dermohypodermal junction. This alteration specifically occurs in women, due to the presence of vertical fascial bands. Piérard [24] believes that cellulite is caused by the genetically determined extension of those fascial bands. This, in turn, weakens and makes the base of the dermal conjunctive tissue thinner and allows the protrusion of fat into the dermo-hypodermic junction, causing the dimpled skin.
Men’s subcutaneous region is composed of horizontal and diagonal fascial bands, which obstruct the herniation of fat [25]. Cellulite is extremely rare in men with normal levels of androgens, regardless of their weight, due to the genetic and hormonal nature of the architecture of the skin.
Hormonal differences are responsible for the structural variations in the anatomy of women’s subcutaneous fat, meaning it is fundamentally regarded as an anatomic alteration [5].
4.2 Vascular Alterations
Cellulite is formed with the weakening of cutaneous vascularization, particularly in response to changes of the arteriolar precapillary sphincter in affected areas, in conjunction with deposits of hyperpolymerized glycosaminoglycans in the dermal capillary walls and between the collagen and elastic fibers [16, 22]. The increase in capillary pressure increases the permeability of the venular capillaries and causes the retention of excess liquid in the dermis, among the adipocytes and the interlobular septa, leading to variations in the cells and tissular hypoxia.
The increase in lipolytic resistance resulting from hypoxia and the increase in lipogenesis—caused by the action of estrogen, prolactin, and a diet rich in carbohydrates—enable the excessive growth of the adipocytes. The enlarged adipocytes, in combination with the growth and hyperplasia of the periadipocyte reticular fibers, form micronodules surrounded by proteins fragments that, later on, cause sclerosis of the fibrous septa, ultimately leading to the appearance of cellulite. Various therapies based on this theory encourage to improve circulation and drainage, with the objective of reducing the dimpled and irregular appearance of the skin [22].
4.3 Inflammatory Factors
Inflammatory factors also form the basis of physiopathology of cellulite [26,27,28]. Though not supported by enough evidence, some studies suggest that septa are responsible for the light inflammation that results in the lysis of the adipocytes and cutaneous atrophy.
Figure 25.1 summarizes the probable factors involved in the etiology of cellulite [29].
5 Differential Diagnosis
Cellulite is sometimes referred to as fat or adipose but there exists a vast difference between them. Adipose tissue known as body fat refers to a type of connective tissue made up of adipocytes, collagen, blood vessels, and nerves. Fat tissue resides as two main reservoirs in the body—visceral fat and subcutaneous fat. Body contouring procedures like liposuction and cryolipolysis target subcutaneous fat. Though subcutaneous fat makes up an element of cellulite, not all subcutaneous fat is cellulite. Cellulite results from the underlying subcutaneous fat herniating between subcutaneous fibrous connective tissue which results in nodularity and dimpling of the skin. Hence treatments which aim to reduce subcutaneous fat fail to lessen cellulite. The proposed complex factors that interact in the formation of cellulite are reduced microcirculation, interstitial liquid infiltration (edema), localized hypertrophy of adipocytes, oxidative stress, and persistent low-grade inflammation, combined with extracellular matrix alterations [30,31,32,33,34]. The extensibility, elasticity, and resilience of the skin are also atypical [35].
Cellulite may be confused with Lipoatrophy which clinically appears as depressions in the skin and may be the consequence of trauma, a history of steroid injections, post-traumatic fat necrosis, or removal of excess subcutaneous tissue during liposuction.
Infragluteal bulges, folds, or protrusions, frequently referred to as a “banana roll,” are the outcome of infragluteal fascial bands present at the base of the gluteal folds that may accentuate adipose tissue inferior to the buttocks [35].
Generalized edema or lymphedema and generalized obesity can also lead to alternating depressions and protrusions of the skin, prominently on the lower extremities, as a result of diminished lymphatic flow or diminished microcirculation.
It is imperative to consider these conditions during the evaluation and treatment since the modalities targeting cellulite may lead to exacerbations in the above-mentioned conditions [35].
6 Classification
Two classifications most commonly used in classifying cellulite are Nurnberger and Muller classification and the other proposed by Hexsel.
In 1978 Nürnberger and Müller classified cellulite into grades created on the clinical presentation of the condition [15]:
-
Grade 0: absence of alterations of the cutaneous surface.
-
Grade I: the surface of the affected area is flat when the patient is lying on his or her back or standing up; however the alterations can be observed when the area is pinched with the fingers or is under contraction of the local musculature.
-
Grade II: an “orange peel” or “padded” appearance is evident without any pinching or muscular contraction when the patient is standing up.
-
Grade III: the alterations described in Grade II are present and combined with elevations and nodulations.
Hexsel proposed a new objective classification by using photonumeric gradations [36]. He designed a more complex scale, composed of 5 variables (ranked 0–3) whose total sum classifies the patient into 1 of 3 groups based on severity: light (1–5 points), moderate (6–10 points), or severe (11–15 points).
The 5 analyzed variables are noted in Table 25.1:
The buttock- and thigh-specific Clinician Reported Photonumeric Cellulite Severity Scale (CR-PCSS) and Patient Reported Photonumeric Cellulite Severity Scale (PR-PCSS) (Fig. 25.2) were postulated to resolve the shortcomings of the above classification scales. These new scales evaluated the cellulite severity, employing a photonumeric reference, cellulite severity and corresponding descriptors, from both physician and patient perspectives. The traditional scales of cellulite severity were assessed using the CR-PCSS and PR-PCSS ratings [37].
7 Treatment
Due to complex, multifactorial and indefinite etiopathogenesis, there is still no effective or absolute treatment. Many therapeutic proposals have been introduced which lack sufficient scientific evidence, durability, and reproducible results. There have been advances in the treatment of cellulite, and the most commonly reviewed treatment options have been discussed ahead.
7.1 Past Treatment Modalities for Cellulite
Microvascular Dysfunction and Tissue Edema
-
1.
Methylxanthines (e.g., caffeine)
-
2.
Mechanical stimulation (manually or with the use of a device)
-
3.
Acoustic wave therapy or extracorporeal shock wave therapy
Excessive Subcutaneous Adipose Tissue
-
1.
Weight loss
-
2.
Cryolipolysis
-
3.
High-intensity focused ultrasound
-
4.
Low-level laser therapy (e.g., wavelengths varying from 532 nm, 635 nm, and 808 nm)
-
5.
High-powered laser therapy (e.g., 1064-nm Nd:YAG)
-
6.
Liposuction
Collagen Denaturation and Tissue Laxity
-
1.
Radiofrequency (unipolar, bipolar, or tripolar)
-
2.
Infrared light
Cellulite treatments mentioned in the international medical literature are classically divided into two groups:
-
Noninvasive
-
Invasive
Both can be further classified as:
-
Treatments that do not involve the use of biologically active substances (medications)
-
Treatments that involve use of active substances
7.2 Noninvasive Treatments Without the Use of Biologically Active Substances
Massage/Endermologie®
In this category lymphatic drainage is the most widespread, due to the hypothesis that alterations in the physiological lymphatic drainage are linked to cellulite’s etiopathogenesis. Massage can be performed manually or using devices designed to obtain higher speed and consistency (e.g., Endermologie® machine) [28, 38, 39].
Light-Based Devices
Intense pulsed light (IPL) and laser belong in this category. IPL is used to stimulate the formation of new collagen and thickening of the dermis, thus making it less susceptible to cellulite. The isolated use of laser is uncommon and scarcely quoted. Many devices combine laser and IPL with massage, vacuum, ultrasound, or multiple techniques in a single device to address several etiopathogenic mechanisms of cellulite such as structural alterations in the collagen, microcirculation, and lymphatic drainage [40].
Dermal Fillers
Recently, fillers like poly-l-lactic acid microspheres and calcium hydroxylapatite (CaHA) combined with MFU-V have been used effectively for improving the appearance of cellulite [41]. When combining these procedures on the same day, the energy device is used first, such as MRF or MFU-V, immediately followed by the injectable biostimulatory agent. If the dermal filler is done first, MRF or MFU-V is performed at least 1 week, preferably 1 month, later [42, 43].
Collagenase Clostridium Histolyticum (CCH)
It is composed of 2 purified collagenases (AUX-I and AUX-II) that hydrolyze collagen under physiologic conditions, resulting in disruption of collagen structures (e.g., fibrous septa) [44]. CCH is approved by the US Food and Drug Administration for the treatment of collagen-associated disorders and has provided benefits in cellulite too [37, 45, 46].
7.3 Noninvasive Treatments with Biologically Active Substances
Topical preparations containing several pharmacological agents have been very commonly used. Topical treatments can be indicated as adjuvant therapies. Agents like methylxanthines, retinoids, lactic acid, and herbal extracts are used alone or in combination. These agents exert their anti-cellulite effects by several biological mechanisms. Methylxanthines such as caffeine, aminophylline, and theophylline have documented action in the treatment of cellulite. Herbal extracts include plants such as forskolin (Coleus forskohlii), sacred lotus (Nelumbo nucifera), carnitine, and escin, Ginkgo biloba, also rich in flavonoids, Centella asiatica, Ruscus aculeatus, and Carica papaya [32]. Topical retinoic and related vitamin A derivates have been also used as topical cellulite treatments.
7.4 Invasive Treatments with Biologically Active Substances
Mesotherapy consists of the injection of multiple substances including xanthines such as caffeine, aminophylline, and theophylline, into the subcutaneous tissue which lead to lipolysis [23].
Carboxytherapy involves injecting carbon dioxide in the subcutaneous tissue with the target of affecting adipose tissue and circulation [47].
7.5 Invasive Treatments Without Biologically Active Substances
Subcision is the invasive surgical technique in which a needle is introduced in the subcutaneous tissue, and subsequently moved parallel to the cutaneous surface with the objective of rupturing the fibrous tissue bands that have a relevant role in cellulite’s etiopathogenesis.
Other options are ultrasonic liposculpture [48,49,50] and autologous transplant of adipose tissue with the application of Nd-Yag laser in the subcutaneous tissue [51].
A treatment algorithm outlining the different cellulite combination treatment, the timespan of the procedures, and the sequence of treatment is given in Table 25.2.
The algorithm shares the entire spectrum of available cellulite treatments ranging from minimally invasive (Option 1) to the most invasive procedures (Option 3) [52]. The multifactorial etiologies in cellulite can be efficiently dealt by utilizing the combination treatments at times in a single session.
8 Conclusion
Cellulite is a condition that negatively impacts quality of life, and there has been enormous growth in available technologies to treat cellulite. Researchers are trying to seek a reliable treatment option for years which can be durable and reproducible. A better understanding of the role fibrous septa play in the pathogenesis of cellulite has led to the emergence of several treatment options that have shown objective, significant, and durable results.
References
Avram MM. Cellulite: a review of its physiology and treatment. J Cosmet Laser Ther. 2004;6(4):181–5.
Terranova F, Berardesca E, Maibach H. Cellulite: nature and aetiopathogenesis. Int J Cosmet Sci. 2006;28(3):157–67.
Lotti T, Ghersetich I, Grappone C, Dini G. Proteoglycans in so-called cellulite. Int J Dermatol. 1990;29(40):272–4.
Rossi ABR, Vergnanini AL. Cellulite: a review. J Eur Acad Dermatol Venereol. 2000;14(4):251–62.
Wanner M, Avram M. An evidence-based assessment of treatments for cellulite. J Drugs Dermatol. 2008;7(4):341–5.
Quatresooz P, Xhauflaire-Uhoda E, Piérard-Franchimont C, Piérard GE. Cellulite histopathology and related mechanobiology. Int J Cosmet Sci. 2006;28(3):207–10.
Emanuele E. Cellulite: advances in treatment: facts and controversies. Clin Dermatol. 2013;31(6):725–30.
Goldman MP. Cellulite: a review of current treatments. Cosmet Dermatol. 2002;15:17–20.
Friedmann DP, Vick GL, Mishra V. Cellulite: a review with a focus on subcision. Clin Cosmet Investig Dermatol. 2017;10:17–23.
Callaghan Rd DJ, Robinson DM, Kaminer MS. Cellulite: a review of pathogenesis-directed therapy. Semin Cutan Med Surg. 2017;36(4):179–84.
Luebberding S, Krueger N, Sadick NS. Cellulite: an evidence-based review. Am J Clin Dermatol. 2015;16(4):243–56.
Hexsel D, Camozzato FO, Silva AF, Siega C. Acoustic wave therapy for cellulite, body shaping and fat reduction. J Cosmet Laser Ther. 2017;19(3):165–73.
Woźniak M, Kaczmarek-Skamira E, Zegarski T, Zegarska B. Cellulite diagnosis: anthropometric interview and research. Dermatol Estet. 2014;1(16):19–22. (Polish).
Grudnik-Wroniszewska M. From diagnosis to therapy. Beauty Forum. 2013;6:20–2. (Polish).
Nurnberger F, Muller G. So-called cellulite: an invented disease. J Dermatol Surg Oncol. 1978;4(3):221–9.
Querleux B, Cornillon C, Jolivet O, Bittoun J. Anatomy and physiology of subcutaneous adipose tissue by in vivo magnetic resonance imaging and spectroscopy: relationships with sex and presence of cellulite. Skin Res Technol. 2002;8:118–24.
de Godoy JMP, de Godoy ACP, Godoy MFG. Considering the hypothesis of the pathophysiology of cellulite in its treatment. Dermatol Rep. 2017;9:7352.
Khan MH, Victor F, Rao B, Sadick NS. Treatment of cellulite: part II. Advances and controversies. J Am Acad Dermatol. 2010;62:373–6; quiz 385–6.
de Godoy JM, de Godoy MF. Physiopathological hypothesis of cellulite. Open Cardiovasc Med J. 2009;3:96–7.
Rao J, Gold MH, Goldman MP. A two-center, double-blinded, randomized trial testing the tolerability and efficacy of a novel therapeutic agent for cellulite reduction. J Cosmet Dermatol. 2005;4:93.
Kligman AM. Cellulite: facts and fiction. J Geriatric Dermatol. 1997;5:136–9.
Alster TS, Tehrani M. Treatment of cellulite with optical devices: an overview with practical considerations. Lasers Surg Med. 2006;38(8):727–30.
Afonso JPJM, Tucunduva TCM, Pinheiro MVB, Bagatin E. Cellulite: a review. Surg Cosmet Dermatol. 2010;2(3):214–9.
Piérard GE, Nizet JL, Pierard-Franchimont C. Cellulite: from standing fat herniation to hypodermal stretch marks. Am J Dermatopathol. 2000;22(1):34–7.
Avram AS, Avram MM, James WD. Subcutaneous fat in normal and diseased states II (anatomy and physiology of white and brown adipose tissue). J Am Acad Dermatol. 2005;53(4):671–9.
Draelos Z, Marenus KD. Cellulite etiology and purported treatment. Dermatol Surg. 1997;23(12):1177–81.
Scherwitz C, Braun-Falco O. So-called cellulite. J Dermatol Surg Oncol. 1978;4(3):230–4.
Collis N, Elliot LA, Sharpe C, Sharpe DT. Cellulite treatment: a myth or reality: a prospective randomized, controlled trial of two therapies, endermologie and aminophylline cream. Plast Reconstr Surg. 1999;104(4):1110–4.
Dupont E, Journet M, Oula ML, Gomez J, Léveillé C, Loing E, Bilodeau D. An integral topical gel for cellulite reduction: results from a double-blind, randomized, placebo-controlled evaluation of efficacy. Clin Cosmet Investig Dermatol. 2014 Feb;20(7):73–88.
Kruglikov I. The pathophysiology of cellulite: can the puzzle eventually be solved? J Cosmet Dermatol Sci Appl. 2012;2(1):1–7.
Khan MH, Victor F, Rao B, Sadick NS. Treatment of cellulite: part I. Pathophysiology. J Am Acad Dermatol. 2010;62(3):361–70.
Hexsel D, Soirefmann M. Cosmeceuticals for cellulite. Semin Cutan Med Surg. 2011;30(3):167–70.
de la Casa Almeida M, Suarez Serrano C, Rebollo Roldán J, Jiménez Rejano JJ. Cellulite’s aetiology: a review. J Eur Acad Dermatol Venereol. 2013;27(3):273–8.
Draelos ZD. The disease of cellulite. J Cosmet Dermatol. 2005;4(4):221–2.
Green JB, Cohen JL. Cellfina observations: pearls and pitfalls. Semin Cutan Med Surg. 2015;34:144–6.
Hexsel DM, Dal’forno T, Hexsel CL. A validated photonumeric cellulite severity scale. J Eur Acad Dermatol Venereol. 2009;23:523–8.
Sadick NS, Goldman MP, Liu G, et al. Collagenase clostridium histolyticum for the treatment of edematous fibrosclerotic panniculopathy (cellulite): a randomized trial. Dermatol Surg. 2019;45(8):1047–56.
Marchand JP, Privat Y. A new instrumental method for the treatment of cellulite. Med Femin. 1991;39:25–34.
Güleç AT. Treatment of cellulite with LPG endermology. Int J Dermatol. 2009;48(3):265–70.
Fink JS, Mermelstein H, Thomas A, Trow R. Use of intense pulsed light and a retinyl-based cream as a potential treatment for cellulite: a pilot study. J Cosmet Dermatol. 2006;5(3):254–62.
Casabona G, Pereira G. Microfocused ultrasound with visualization and calcium hydroxylapatite for improving skin laxity and cellulite appearance. Plast Reconstr Surg Glob Open. 2017;5:e1388.
England LJ, Tan MH, Shumaker PR, Egbert BM, et al. Effects of monopolar radiofrequency treatment over soft-tissue fillers in an animal model. Lasers Surg Med. 2005;37:356–65.
Shumaker PR, England LJ, Dover JS, Ross EV, et al. Effect of monopolar radiofrequency treatment over soft-tissue fillers in an animal model: part 2. Lasers Surg Med. 2006;38:211–7.
French MF, Mookhtiar KA, VanWart HE. Limited proteolysis of type I collagen at hyperreactive sites by class I and II Clostridium histolyticum collagenases: complementary digestion patterns. Biochemistry. 1987;26:681–7.
Goldman M, Sadick N, Young L, Kaufman GJ, et al. Phase 2a, randomized, double-blind, placebo-controlled dose-ranging study of repeat doses of collagenase clostridium histolyticum for the treatment of edematous fibrosclerotic panniculopathy (cellulite). J Am Acad Dermatol. 2015;72:AB19.
Dagum B, Badalamente MA. Collagenase injection in the treatment of cellulite. Presented at: Plastic surgery; October 6–11, 2016; San Francisco, CA.
Brandi C, D’Aniello C, Grimaldi L, Bosi B, Dei I, Lattarulo P, et al. Carbon dioxide therapy in the treatment of localized adiposities: clinical study and histopathological correlations. Aesthet Plast Surg. 2001;25(3):170–4.
Gasparotti M. Superficial liposuction: a new application of the technique for aged and flaccid skin. Aesthet Plast Surg. 1992;16(1):141–53.
Karnes J, Salisbury M, Schaeferle M, Beckham P, Ersek RH, et al. Hip lift. Aesthet Plast Surg. 2002;26(1):126–9.
Adamo C, Mazzocchi M, Rossi A, Scuderi N. Ultrasonic liposculpturing: extrapolations from the analysis of in vivo sonicated adipose tissue. Plast Reconstr Surg. 1997;100(1):220–6.
Goldman A, Gotkin RH, Sarnoff DS, Prati C, Rossato F. Cellulite: a new treatment approach combining subdermal Nd:YAG laser lipolysis and autologous fat transplantation. Aesthet Surg J. 2008;28(6):656–62.
Davis DS, Boen M, Fabi SG. Cellulite: patient selection and combination treatments for optimal results—a review and our experience. Dermatol Surg. 2019;45(9):1171–84.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Agarwal, M. (2022). Treatment of Cellulite. In: Sarkar, R., Sinha, S. (eds) Skin Diseases in Females. Springer, Singapore. https://doi.org/10.1007/978-981-16-6065-8_25
Download citation
DOI: https://doi.org/10.1007/978-981-16-6065-8_25
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-6064-1
Online ISBN: 978-981-16-6065-8
eBook Packages: MedicineMedicine (R0)